Mohs micrographic surgery in the treatment of non-melanocytic skin neoplasms
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2021.170517Keywords:
Mohs surgery, Skin neoplasms, Systematic reviewAbstract
Objective: Evaluating the effectiveness of using MOHS surgery in the management of non-melanoma skin tumors compared to other therapy methods. Methods: The study consists of a systematic review, whose search for articles was performed using databases MEDLINE, PubMed Central (PMC), LILACS and SciELO, using the terms “MOHS surgery”, “Skin cancer”, “Clinical trial”, excluding “melanoma”. Results: from a total of 132 identified articles, 11 were considered eligible. The analysis of the articles showed that MMS, compared to other methods, presented better cosmetic results, in addition to a lower grade of complications in recurrent tumors and a variable cost/benefit according to the country where the surgery was performed. MMS also had lower recurrence rates in all studies. Conclusion: Overall, MOHS surgery has shown promising therapeutic results. However, there are still few comparative studies on the effectiveness of MMS and those that exist are concentrated in a few regions of the world.
Downloads
References
Ladda MA, Lynde CW. Mohs Micrographic Surgery: Development of the Technique. J cutan medic surger. 2019; 23(2): 236.
Wong E, Axibal E, Brown M. Mohs Micrographic Surgery. Facial Plast Surg Clin North Am. 2019; 27(1): 15-34.
Van loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, et al. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year followup. Eur J Cancer. 2014; 50(17): 3011–20.
Kauvar AN, Cronin JRT, Roenigk R, Hruza G, Bennett R. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg. 2015; 41(5): 550-71.
Tanese K. Diagnosis and Management of Basal Cell Carcinoma. Curr Opin Oncol. 2019; 20(2): 1-13.
Murray C, Silva JD, Hanna TP, Bradshaw S, Solish N, Moran B, et al. Patient indications for Mohs micrographic surgery: a clinical practice guideline. Curr Opin Oncol. 2019; 26(1): 94-99.
Sanchez FH, Estefan JL, Estefan LL. Cirurgia micrográfica de Mohs: estudo de 93 tumores operados em um centro de referência no Rio de Janeiro. Surg Cosm Derm. 2013; 5(3): 206-10.
Pontes LT. Cirurgia micrográfica de Mohs em um serviço universitário: estudo retrospetivo de 5 anos [dissertação]. Campinas: Universidade Estadual de Campinas, Faculdade de Ciências Médicas; 2016.
Reeder VJ, Gustafson C J, Mireku K, Davis SA, Feldman SR, Pearce DJ. Trends in Mohs surgery from 1995 to 2010: an analysis of nationally representative data. Derm Surg. 2015; 41(3): 397-403
Correia STR, Silva R, Lopes JM. Carcinoma basocelular da pele (parte 2): diagnóstico, prognóstico e manejo. Future Oncology. 2015; 11(22): 3023-38.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Itens de relatório preferidos para revisões sistemáticas e metanálises: a declaração PRISMA. PLoS Med. 2009; 6(7): e1000097.
Patel R, Strimling R, Doggett S, Willoughby M, Miller K, Dardick L, et al. Comparison of electronic brachytherapy and Mohs micrographic surgery for the treatment of early-stage non-melanoma skin cancer: a matched pair cohort study. J Contemp Brachytherapy. 2017; 9(4): 338–44.
Essers BAB, Dirksen CD, Nieman FHM, Smeets NWJ, Krekels GAM, Prins MH, et al. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face. Arch Dermatol. 2006; 142(2): 187-94.
Smeets NWJ, Krekels GAM, Ostertag JU, Essers BAB, Dirksen CD, Nieman FHM, et al. Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet. 2004; 364(9447): 1766–72.
Davis JL, Randle HW, Zalla MJ, Roenigk RK, Brodland DG. A comparison of Mohs Micrografic Surgery and wide excision for the treatment of atypical fibroxantoma. Dermatol Surg. 1997; 23(2): 105-10.
Tolkachjov SN, Kelley BF, Alahdab F, Erwin PJ, Brewer JD. Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision. J Am Acad Dermatol. 2008; 79(5): 929-34.
Dubay D, Cimmino V, Lowe L, Johnson TM, Sondak VK. Low Recurrence Rate after Surgery for Dermatofibrosarcoma Protuberans: a multidisciplinary approach from a single institution. Cancer. 2004; 100(5): 1008–16.
Boyer JD, Ziteli JA, Brodland DG, D`Angelo G. Local control of primary Merkel cell carcinoma: Review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol. 2002; 47(6): 885-92.
Wain RAJ, Tehrani H. Reconstructive outcomes of Mohs surgery compared with conventional excision: A 13-month prospective study. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2015; 68(7): 946-52
Chren MM, Sahay AP, Bertenthal DS, Sen S, Landerfeld CS. Quality of Life Outcomes of Treatments for Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma. Journal of Investig Dermatol. 2007; 127(6): 1351–57.
Muller FM, Dawe RS, Moseley H, Fleming CJ. Randomized Comparison of Mohs Micrographic Surgery and Surgical Excision for Small Nodular Basal Cell Carcinoma: Tissue-Sparing Outcome. Dermatol Surg. 2009; 35(9): 1349-54.
Ravitskiy L, Brodland DG, Zitelli JA. Cost Analysis: Mohs Micrographic Surgery. Dermatol Surg. 2012; 38(4): 585–94.
Cook J, Ziteli JA. Mohs micrographic surgery: A cost analysis. J Am Acad Dermatol. 1998; 39(5): 698-703
Downloads
Published
Issue
Section
License
Copyright (c) 2021 João Augusto Gomes de Souza Monteiro de Brito, Lucas da Silva Lopes, Ana Luísa Gross Rodrigues, Caio Vinicius Botelho Brito
This work is licensed under a Creative Commons Attribution 4.0 International License.
